A research-related injury is any harm caused by taking part in a study — and before you join one, federal rules require the consent form to tell you whether treatment for that injury is available, whether compensation is offered, and who to contact if it happens. This guide turns that specific disclosure requirement into a short list of questions you can ask before signing anything. It is not legal or financial advice.
Picture this: someone with a knee injury is offered a spot in a regenerative-medicine study. The consent form is long. The coordinator answers questions about the procedure itself — how many visits, what the injection involves, how recovery usually goes. But one question rarely gets asked out loud: if this procedure injures me, who pays for fixing it?
What Does Federal Law Actually Require the Consent Form to Say About Injury?
Studies on people in the United States are governed by rules from the U.S. Department of Health and Human Services (HHS), specifically a regulation known as 45 CFR 46.116(a). For any study with more than “minimal risk,” the consent form must include two specific things about a research-related injury:
- An explanation of whether medical treatment is available if you’re injured by the research, and if so, what that treatment consists of — or where you can go to find out.
- An explanation of whether any compensation is offered for a research-related injury.
The form must also name whom to contact if you’re injured during the study, separate from who you’d contact with general questions about the research. This is verified, sourced language from HHS’s Office for Human Research Protections (OHRP) — not a summary of what studies “usually” do. For more on how we verify language like this, see our How We Research page.
Why Doesn’t the Rule Guarantee Who Pays for a Research Injury?
Here is the detail that surprises most people: the regulation requires the form to say whether treatment and compensation exist. It does not require that either one actually be offered, and it sets no national standard for who pays if the answer is “no free treatment is provided.”
That means two studies can both be fully compliant with federal law while giving completely different answers to “who pays if something goes wrong.” One might cover treatment costs for a related injury. Another might state plainly that you or your insurance would be responsible. Both are allowed — as long as the form tells you which one applies. This is why reading the injury section carefully, and asking about anything vague or missing, matters more than most people realize.
Is an Expanded Access Program the Same as Joining a Clinical Trial?
Some people encounter a different route into an unapproved treatment, called “expanded access” (sometimes called compassionate use), where a patient outside a formal study may be given an investigational drug or product for treatment rather than research. FDA guidance on this pathway confirms that expanded access still requires informed consent under separate FDA regulations and still requires review by an Institutional Review Board (IRB) — the same kind of independent safety committee that oversees clinical studies.
If you’re evaluating a regenerative-medicine offer, ask directly which category it falls into — a formal research study, an expanded access arrangement, or something else — because the injury-disclosure and consent requirements can differ.
What Are the Warning Signs You Shouldn’t Sign Yet?
If any of the following is true, slow down and get clear answers before proceeding:
- The consent form has no section addressing injury, treatment, or compensation at all.
- You’re told “don’t worry about that” when you ask who pays for a complication.
- You’re asked to sign the same day you first hear about the study, with no time to take the form home or ask someone else to review it.
- Nobody can give you a name or phone number to call if something goes wrong after the procedure.
- You feel rushed, or the pitch seems designed to move you past the paperwork rather than through it.
If you ever experience a medical emergency — severe pain, bleeding, infection signs, or any symptom that feels urgent — contact local emergency services or go to an emergency room immediately. Do not wait to reach a study coordinator first.
What Questions Should You Ask Before You Join a Study?
Bring this list, in your own words, to the consent conversation. A legitimate study team should be able to answer every one of these without hesitation.
- Coverage: “If I’m injured by this procedure, is any medical treatment provided at no cost to me, or would I be billed?”
- Compensation: “Beyond treatment, is there any compensation offered for a research-related injury, such as lost wages or pain and suffering?”
- Contact: “Who do I call, specifically, if something goes wrong after my appointment — and is that different from the number I’d use for general questions?”
- Documentation: “Can I get this injury-and-compensation information in writing, separate from the full consent form, so I can review it later?”
- Category: “Is this a formal research study, an expanded access arrangement, or a different kind of program?”
- Insurance: “Would my own health insurance be expected to cover any complications, and has anyone confirmed that with my plan?”
- Timeline: “How long do I have to review this consent form before I need to decide?”
What Is the Decision Path Before You Sign a Consent Form?
Use these three stages to pace yourself instead of deciding everything in one conversation.
- Before you meet the study team: If a study team offers you the consent form in advance, read the injury and compensation section first, before anything else.
- During the consent conversation: If an answer to a checklist question above is vague, ask for it again in plain terms and write down what you’re told, including the specific injury-contact name and number.
- Before you sign: If you feel rushed or an answer stays vague, ask for a written follow-up before signing rather than relying on a verbal promise — take the full review time the form allows.
Common Questions About Research Injury Costs
Does federal law require a study to pay for a research-related injury?
No. Federal rules require the consent form to state whether treatment and compensation are available, but they do not require either one to actually be provided. Whether you or your insurance would be responsible depends on the specific study.
What exactly must my consent form tell me about injury?
It must explain whether medical treatment is available if you’re injured, what that treatment involves (or where to find out), and whether any compensation is offered — plus a contact specifically for research-related injury.
Who do I contact if I’m injured during a study?
Your consent form is required to name a contact for research-related injury that is separate from the general contact for research questions. If you can’t find this information, ask for it before signing.
Is expanded access the same thing as joining a clinical trial?
No. Expanded access is a different regulatory pathway for accessing an investigational treatment outside a formal study, but FDA guidance confirms it still requires informed consent and independent review by an Institutional Review Board.
What should I do if the injury section is missing from my consent form?
Ask for it in writing before you sign. A study that can’t or won’t answer who pays for treatment or what compensation is offered is a reason to slow down, not a detail to skip past.
What This Guide Is — and Isn’t
This article explains what federal informed-consent rules require studies to disclose about research-related injury, and turns that requirement into questions you can ask. It does not evaluate any specific study, clinic, or product, and it is not medical, legal, or financial advice — see our full Medical Information Disclaimer. Decisions about joining a research study should be made with the study’s own team, and, where helpful, an independent doctor or attorney who has no connection to the study.
For general background on how we evaluate regenerative-medicine claims and sourcing, see our Start Here guide and our Editorial Policy.
Sources
- U.S. Department of Health and Human Services, Office for Human Research Protections — Informed Consent FAQ (45 CFR 46.116(a) elements, research-related injury and contact disclosure requirements)
- U.S. Food and Drug Administration — Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers (informed consent and IRB review requirements for expanded access)
This article is for general education only and is not medical, legal, or financial advice. Regenerative Evidence Guide is an independent educational publication and is not affiliated with any clinic, research sponsor, academy, or training program formerly associated with this domain. If you are experiencing a medical emergency, contact local emergency services immediately.
By Regenerative Evidence Guide Editorial Team. Updated September 10, 2026.
This content is for informational and educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your health routine, medications, or supplements.
Leave a Reply